Author

Kurosh Rahimi

Centre Hospitalier de l’Université de MontréalORCID 0000-0001-9052-9415Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:experimental assay· 1 Research Focus:protein structure prediction· 1 Research Focus:spatial domain detection· 1

Frequent Co-Authors

Anne‐Marie Mes‐MassoniD· 2 shared Diane Michele ProvencheriD· 2 shared Françis RodieriD· 2 shared Isabelle Clément· 2 shared Michael Skulimowski· 2 shared Eurídice Carmona· 1 shared Hubert Fleury· 1 shared Jessica BourbonnaisiD· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Anne‐Marie Mes‐MassonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintSep 30, 2023

A senescence-like state is beneficial for ovarian cancer treatment

Michael Skulimowski, Llilians Calvo, Shuofei Cheng…·Françis Rodier

This study shows that senescence in ovarian cancer cells after chemotherapy correlates with better patient survival, suggesting senescence could be a therapeutic target.

DOI 10.1101/2023.09.30.560300

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintSep 30, 2023

53BP1 mediates sensitivity to chemotherapy and is associated with poor clinical outcomes in high-grade serous ovarian cancer

Michael Skulimowski, Jessica Bourbonnais, Nicolas Malaquin…·Françis Rodier

This study shows that high 53BP1 levels in ovarian cancer are linked to poor survival and chemotherapy resistance, suggesting it could be a therapeutic target.

DOI 10.1101/2023.09.30.560286

humanbulk RNA-seq

𝕏 PostBluesky